Saxonov Serge sold TXG

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001610717-26-000393

Machine-readable

Structured copy

Timestamps

Event (reported)

Aug 26, 2026

Published

Aug 28, 2026

Ingested by INSIDER

Nov 5, 02:20 UTC

Last re-read

Nov 5, 02:20 UTC

Extracted facts

Filer

Saxonov Serge

Role

Director, Chief Executive Officer

Transaction

Open-market saleAs filed: “S”

Asset

10x Genomics, Inc.

Ticker

TXG

Shares

3,500

Price per share

$63.02

Value

$220,580

Execution date (reported)

Aug 26, 2026

Owned after transaction

1.08M shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

2

Calculation

What this establishes

Saxonov Serge filed this Form 4 reporting a open-market sale of TXG on Aug 26, 2026. It became public on Aug 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, Chief Executive Officer

Saxonov Sergecik:0001786720

Issuer

10x Genomics, Inc.cik:0001770787

Revision history · 0

No field has changed since this record was first ingested.